Key industry trends and how the relationships between companies and CDMOs are evolving to better meet the challenges of a BANI world.
Jimmy Wei, PhD
Advertisement
President, Chime Biologics
Articles by Jimmy Wei, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
InnoCare Enters $3.35 Billion Research Collaboration and License Agreement with Eli Lilly
2
From Experimentation to Execution: Strategic AI Adoption and Clinical Data Harmonization in Life Sciences
3
FDA Approves Onswik for Adults with Type 2 Diabetes
4
The Legacy of Rutledge: How States and Congress Can Still Regulate Pharmacy Benefit Managers
5